Logo image of NRST.MI

NEUROSOFT (NRST.MI) Stock Fundamental Analysis

Europe - BIT:NRST - GRS802003004 - Common Stock

0.83 EUR
+0.02 (+2.47%)
Last: 9/11/2025, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, NRST scores 5 out of 10 in our fundamental rating. NRST was compared to 69 industry peers in the IT Services industry. NRST has only an average score on both its financial health and profitability. While showing a medium growth rate, NRST is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

NRST had positive earnings in the past year.
In the past year NRST had a positive cash flow from operations.
NRST had positive earnings in 4 of the past 5 years.
In multiple years NRST reported negative operating cash flow during the last 5 years.
NRST.MI Yearly Net Income VS EBIT VS OCF VS FCFNRST.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M

1.2 Ratios

NRST has a Return On Assets of 7.10%. This is in the better half of the industry: NRST outperforms 76.81% of its industry peers.
NRST has a better Return On Equity (20.25%) than 82.61% of its industry peers.
NRST has a Return On Invested Capital of 17.16%. This is amongst the best in the industry. NRST outperforms 91.30% of its industry peers.
NRST had an Average Return On Invested Capital over the past 3 years of 17.86%. This is significantly above the industry average of 11.46%.
Industry RankSector Rank
ROA 7.1%
ROE 20.25%
ROIC 17.16%
ROA(3y)7.57%
ROA(5y)0.99%
ROE(3y)21.13%
ROE(5y)-0.29%
ROIC(3y)17.86%
ROIC(5y)N/A
NRST.MI Yearly ROA, ROE, ROICNRST.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

NRST has a Profit Margin of 4.45%. This is in the better half of the industry: NRST outperforms 60.87% of its industry peers.
In the last couple of years the Profit Margin of NRST has declined.
NRST has a Operating Margin of 6.35%. This is comparable to the rest of the industry: NRST outperforms 50.72% of its industry peers.
NRST's Operating Margin has improved in the last couple of years.
The Gross Margin of NRST (22.13%) is worse than 73.91% of its industry peers.
NRST's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.35%
PM (TTM) 4.45%
GM 22.13%
OM growth 3Y17.59%
OM growth 5YN/A
PM growth 3Y-7.93%
PM growth 5YN/A
GM growth 3Y-0.34%
GM growth 5Y20.48%
NRST.MI Yearly Profit, Operating, Gross MarginsNRST.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

6

2. Health

2.1 Basic Checks

NRST has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, NRST has about the same amount of shares outstanding.
Compared to 5 years ago, NRST has about the same amount of shares outstanding.
Compared to 1 year ago, NRST has about the same debt to assets ratio.
NRST.MI Yearly Shares OutstandingNRST.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
NRST.MI Yearly Total Debt VS Total AssetsNRST.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

An Altman-Z score of 3.31 indicates that NRST is not in any danger for bankruptcy at the moment.
NRST has a better Altman-Z score (3.31) than 72.46% of its industry peers.
NRST has a debt to FCF ratio of 2.94. This is a good value and a sign of high solvency as NRST would need 2.94 years to pay back of all of its debts.
NRST has a Debt to FCF ratio of 2.94. This is comparable to the rest of the industry: NRST outperforms 57.97% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that NRST is not too dependend on debt financing.
NRST has a Debt to Equity ratio of 0.25. This is in the better half of the industry: NRST outperforms 68.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 2.94
Altman-Z 3.31
ROIC/WACC1.28
WACC13.37%
NRST.MI Yearly LT Debt VS Equity VS FCFNRST.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M

2.3 Liquidity

A Current Ratio of 1.50 indicates that NRST should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.50, NRST is in the better half of the industry, outperforming 73.91% of the companies in the same industry.
NRST has a Quick Ratio of 1.45. This is a normal value and indicates that NRST is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.45, NRST is doing good in the industry, outperforming 76.81% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.45
NRST.MI Yearly Current Assets VS Current LiabilitesNRST.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

NRST shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.60%, which is quite impressive.
NRST shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 23.37% yearly.
Looking at the last year, NRST shows a very strong growth in Revenue. The Revenue has grown by 38.98%.
Measured over the past years, NRST shows a very strong growth in Revenue. The Revenue has been growing by 20.54% on average per year.
EPS 1Y (TTM)31.6%
EPS 3Y23.37%
EPS 5YN/A
EPS Q2Q%79.48%
Revenue 1Y (TTM)38.98%
Revenue growth 3Y33.98%
Revenue growth 5Y20.54%
Sales Q2Q%40.31%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NRST.MI Yearly Revenue VS EstimatesNRST.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

NRST is valuated reasonably with a Price/Earnings ratio of 11.86.
Based on the Price/Earnings ratio, NRST is valued cheaply inside the industry as 84.06% of the companies are valued more expensively.
NRST's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.38.
Industry RankSector Rank
PE 11.86
Fwd PE N/A
NRST.MI Price Earnings VS Forward Price EarningsNRST.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NRST indicates a somewhat cheap valuation: NRST is cheaper than 69.57% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NRST indicates a slightly more expensive valuation: NRST is more expensive than 60.87% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 21.69
EV/EBITDA 5.64
NRST.MI Per share dataNRST.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1

4.3 Compensation for Growth

The decent profitability rating of NRST may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

NRST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEUROSOFT

BIT:NRST (9/11/2025, 7:00:00 PM)

0.83

+0.02 (+2.47%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap21.23M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.86
Fwd PE N/A
P/S 0.56
P/FCF 21.69
P/OCF 9.24
P/B 2.55
P/tB 2.72
EV/EBITDA 5.64
EPS(TTM)0.07
EY8.43%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.04
FCFY4.61%
OCF(TTM)0.09
OCFY10.82%
SpS1.48
BVpS0.33
TBVpS0.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.1%
ROE 20.25%
ROCE 22.78%
ROIC 17.16%
ROICexc 18.8%
ROICexgc 19.84%
OM 6.35%
PM (TTM) 4.45%
GM 22.13%
FCFM 2.58%
ROA(3y)7.57%
ROA(5y)0.99%
ROE(3y)21.13%
ROE(5y)-0.29%
ROIC(3y)17.86%
ROIC(5y)N/A
ROICexc(3y)31.1%
ROICexc(5y)N/A
ROICexgc(3y)40.94%
ROICexgc(5y)N/A
ROCE(3y)23.72%
ROCE(5y)N/A
ROICexcg growth 3Y2.9%
ROICexcg growth 5YN/A
ROICexc growth 3Y10.94%
ROICexc growth 5YN/A
OM growth 3Y17.59%
OM growth 5YN/A
PM growth 3Y-7.93%
PM growth 5YN/A
GM growth 3Y-0.34%
GM growth 5Y20.48%
F-Score8
Asset Turnover1.6
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 2.94
Debt/EBITDA 0.51
Cap/Depr 77.43%
Cap/Sales 3.48%
Interest Coverage 54.57
Cash Conversion 55.91%
Profit Quality 58.1%
Current Ratio 1.5
Quick Ratio 1.45
Altman-Z 3.31
F-Score8
WACC13.37%
ROIC/WACC1.28
Cap/Depr(3y)62.29%
Cap/Depr(5y)44.17%
Cap/Sales(3y)3.06%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.6%
EPS 3Y23.37%
EPS 5YN/A
EPS Q2Q%79.48%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)38.98%
Revenue growth 3Y33.98%
Revenue growth 5Y20.54%
Sales Q2Q%40.31%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y36.05%
EBIT growth 3Y57.54%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y140.08%
FCF growth 3Y5.24%
FCF growth 5YN/A
OCF growth 1Y235.8%
OCF growth 3Y27.48%
OCF growth 5Y66.65%